The FDA has granted CircuLite investigational device exemption approval to launch a clinical study of its SYNERGY Circulatory Support System, which uses an implanted canula to pump oxygenated blood in the heart. The device could provide hard-to-treat terminal patients with a minimally invasive alternative to bypass or open-heart surgery.
CircuLite gains FDA approval for blood pump study
SmartBrief Job Listings for Health Care
|Sr. Business Systems Analyst||
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Leadership Recruiting Manager||
|Sr. Reimbursement Analyst||
Olympus America Inc.
|Sr. Report Developer Medical Claims||
Geisinger Health System